Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Singapore Institute Of Advanced Medicine Holdings Buyback Yield %?
Singapore Institute Of Advanced Medicine HoldingsSGX:9G2 Buyback Yield % is -30.22 as of Sep. 11, 2026. The stock has 3 warning signs investors should review. Among 247 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 88.66% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings Buyback Yield % Chart
Singapore Institute Of Advanced Medicine Holdings Annual Data
SGX:9G2 vs HCA, THC, EHC: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Institute Of Advanced Medicine Holdings Buyback Yield % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Buyback Yield % of -30.22 as of Sep. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #219 out of 247 companies in the Healthcare Providers & Services industry, placing it in the top 88.7%.
Is Singapore Institute Of Advanced Medicine Holdings' Buyback Yield % too high?
Singapore Institute Of Advanced Medicine Holdings' current Buyback Yield % is -30.22. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #219 out of 247 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #219 out of 247 companies for Buyback Yield %. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. Singapore Institute Of Advanced Medicine Holdings's current Buyback Yield % is -30.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Based on GuruFocus' analysis, Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.04, compared to a current price of S$0.03 — trading 32.5% below its estimated fair value. The current Buyback Yield % is -30.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Buyback Yield % is -30.22 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:9G2 has been successfully added to your 
